Board-Certified Dermatologist
Board-Certified Mohs Surgeon
Fellowship-Trained Mohs Surgeon

Kelly Wilmas, MD, FAAD

Kelly Wilmas, MD, is a board-certified dermatologist, board-certified Mohs surgeon, and ACGME fellowship-trained Mohs micrographic and reconstructive surgeon. Dr. Wilmas earned her medical degree from the University of Texas Medical School at Houston where she was inducted into the Alpha Omega Alpha and Gold Humanism Honor Societies. She completed her dermatology residency at the University of Texas MD Anderson Cancer Center, distinguished as the nation’s top cancer center. During her final year, she served as Chief Resident. She completed a fellowship in Mohs Micrographic Surgery and Dermatologic Oncology at the University of California San Francisco, regarded as one of the most prestigious fellowships in the country.

Dr. Wilmas has a passion for evidence-based medicine and the improvement of patient outcomes. This has led to numerous lectures, national research presentations, publications in peer-reviewed journals including Cancers, Dermatologic Surgery, and Journal of the American Academy of Dermatology. She has received multiple awards for clinical care, education, and research, and was named “Top Advocate” by the American Society for Dermatologic Surgery Association for her commitment to patient safety.

Dr. Wilmas specializes in Mohs micrographic surgery (a precise technique for removing skin cancer while sparing healthy tissue), surgical reconstruction, skin cancer detection and management, and cosmetic dermatology.

As a native of St. Louis, Dr. Wilmas is honored to care for the people of Missouri.

West County

12855 N. Outer 40 Road
Suite 180

St. Louis, Missouri 63141

Tel:(314) 878-5599

Farmington

1223 Maple Street

Farmington, Missouri 63640

Tel:(573) 760-8811

Webster Groves

8567 Watson Road
Suite A

Webster Groves, Missouri 63119

Tel:(314) 528-9040

Arnold

130 Richardson Crossing
Suite 130

Arnold, Missouri 63010

Tel:(636) 489-4770

It is a privilege to provide care to patients affected by skin conditions, to establish meaningful connections with them, and to improve their overall well-being.

- Kelly Wilmas, MD, FAAD, FACMS

Education

Undergraduate Degree:

University of Texas at Austin, Austin, TX

Medical Degree:

University of Texas Medical School at Houston, Houston, TX

Internship:

University of Texas Health Science Center at Houston, Houston, TX

Dermatology Residency

University of Texas MD Anderson Cancer Center, Houston, TX

Micrographic Surgery and Dermatologic Oncology Fellowship

University of California San Francisco, San Francisco, CA

Certificates

American Board of Dermatology

Professional Memberships

American Academy of Dermatology
American Society for Dermatologic Surgery
Women’s Dermatologic Society
American Society for Laser Medicine & Surgery
American Contact Dermatitis Society

Publications

Wilmas K, Patel J, Silapunt S, Doan HQ, Migden MR. The use of a dehydrated complete human placental membrane allograft for Mohs surgical defects of the nose. Dermatologic Surgery, 2023 Feb 13. PMID: 36799879.

Chen O, Kim K, Steele C, Wilmas KM, Aboul-Fettouh N, Burns C, Doan HQ, Silapunt S, Migden MR. Advances in Management and Therapeutics of Cutaneous Basal Cell Carcinoma. Cancers. 2022 Jul 30;14(15):3720. PMID: 35954384.

Burns C, Kubicki S, Nguyen QB, Aboul-Fettouh N, Wilmas KM, Chen O, Doan HQ, Silapunt S, Migden MR. Advances in Cutaneous Squamous Cell Carcinoma Management. Cancers. 2022 Jul 27;14(15):3653. PMID: 35954316

Wilmas KM, Aria AB, Landis LN, Chaitanya SK, Prieto VG, Duvic M. CD4/CD8 double-negative mycosis fungoides with large cell transformation and involvement of the lungs and leptomeninges. Dermatology Online Journal. 2022 Mar 15;28(2):4. PMID: 35670681.

McNally M, Patel A, Wilmas KM, Thomas V, Heberton M. Cutaneous Surgery Outcomes in Patients on Epidermal Growth Factor Receptor Inhibitors. Dermatologic Surgery. 2021 Nov 1; 47(11):1519-1521. PMID: 34417386.

Wilmas KM, Nguyen QB, Patel J, Silapunt S, Migden MR. Treatment of advanced cutaneous squamous cell carcinoma: Mohs surgery & cutaneous oncology perspective. Future Oncology. 2021 Dec; (35):4971-4982. PMID: 34608809.

Wilmas KM, Garner W, Ballo M, McGovern S, MacFarlane DF. The role of radiation therapy in the management of cutaneous malignancies. Part I: Diagnostic modalities and applications. Journal of the American Academy of Dermatology. 2021 Sep; 85(3):539-548. PMID: 34116097.

Wilmas KM, Garner W, Ballo M, McGovern S, MacFarlane DF. The role of radiation therapy in the management of cutaneous malignancies. Part II: When is radiation therapy indicated? Journal of the American Academy of Dermatology. 2021 Sep; 85(3):551-562. PMID: 34116100.

Kim E, Aria A, Wilmas K, Lewis D, Dabaja B, Nunez C, Torres-Cabala C, Duvic M. Small-to-medium pleomorphic CD4+ T-cell lymphoproliferative disorder in a pediatric patient successfully treated with low-dose radiation. Pediatric Dermatology. 2019 Jan;36(1):e23-e26. PMID: 30548331.

Aria A, Wilmas K, Kim E, Aung P, Duvic M. The development of primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoproliferative disorder at the site of a melanoma excision scar. Dermatology Online Journal. 2018 Sep;24(9). PMID: 30677830.

Wilmas K, Aria A, Torres-Cabala C, Lu H, Duvic M. Schnitzler’s syndrome in a patient with a family history of monoclonal gammopathy. Dermatology Online Journal. 2018 Jan;24(1). PMID: 29469761.

Jenkinson HA, Wilmas KM, Silapunt S. Sodium tetradecyl sulfate: A review of clinical uses. Dermatologic Surgery. 2017 Nov;43(11):1313-1320. PMID: 28430735.

*Age Restriction

For patients scheduling who are under 18 years of age (19 in Alabama) please make sure you have permission from your parent or legal guardian to schedule this appointment. Your parent or legal guardian must accompany you on your initial visit and on certain subsequent visits to provide appropriate informed consent.